Chemical process vs. patents Changing trends in process R&D of API's in generic pharma industries

摘要

Challenges faced to implement the basic scientific knowledge to Chemical Process Research and Development (CPR&D) of generic drugs targeted for global market is getting complex like never before due to continuously emerging patent landscape, increased competition, regulatory hurdles and the cost pressure. The "need for innovation" scenario is more "driven and dictated bylntelleefuai Property (IP), which has thereby compelled scientists to think out of the box to overcome these challenges, in this-report,; we present envisaged hurdles that the scientists in the CPR&D section of generic pharmaceutical industry may face to withstand the "patent; storm" and the strategies employed to emerge out as a global leader.